It has also been suggested that PD-1/PD-L1 function is impaired in patients with vitiligo, leading to loss of peripheral tolerance and ineffective suppression of autoreactive T cells, which in turn attack melanocytes. This evidence concerns the gene CD274 and vitiligo.